Delphinidin-3-O-rutinoside chloride
CAS No. 15674-58-5
Delphinidin-3-O-rutinoside chloride( —— )
Catalog No. M31220 CAS No. 15674-58-5
Delphinidin-3-O-rutinoside chloride has antioxidant activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 267 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameDelphinidin-3-O-rutinoside chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDelphinidin-3-O-rutinoside chloride has antioxidant activity.
-
DescriptionDelphinidin-3-O-rutinoside chloride has antioxidant activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15674-58-5
-
Formula Weight645
-
Molecular FormulaC27H31O16Cl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
6-NBDG
6-NBDG, a fluorescent glucose analogue, can be used as a fluorescent probe.6-NBDG can be used for monitoring glucose transport and uptake. 6-NBDG can be used as for detecting macrophage-rich atherosclerotic plaques.
-
lorvotuzumab
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.
-
Antagonist G
Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.
Cart
sales@molnova.com